Zum Inhalt

Inflammopharmacology

Ausgabe 3/2012 Special Issue: Inflammation in acute and chronic neurological and psychiatric diseases

Inhalt (7 Artikel)

Inflammation in neurological and psychiatric diseases

  • Inflammation in acute and chronic neurological and psychiatric diseases

Parto S. Khansari, Beata Sperlagh

The role of inflammatory processes in Alzheimer’s disease

  • Inflammation in acute and chronic neurological and psychiatric diseases

G. Joseph Broussard, Jennifer Mytar, Rung-chi Li, Gloria J. Klapstein

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

  • Inflammation in Acute and Chronic Neurological and Psychiatric Diseases

Michael Maes, Zdenĕk Fišar, Miguel Medina, Giovanni Scapagnini, Gabriel Nowak, Michael Berk

Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors

  • Inflammation in acute and chronic neurological and psychiatric diseases

Kyoungho Suk, Jiyeon Ock

NSAIDs in the treatment and/or prevention of neurological disorders

  • Inflammation in acute and chronic neurological and psychiatric diseases

Parto S. Khansari, Leanne Coyne

Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients

  • Inflammation in acute and chronic neurological and psychiatric diseases

Daniela L. Krause, Michael Riedel, Norbert Müller, Elif Weidinger, Markus J. Schwarz, Aye-Mu Myint

Anti-inflammatory properties and pharmacological induction of Hsp70 after brain injury

  • Inflammation in acute and chronic neurological and psychiatric diseases

Nuri Kim, Jong Youl Kim, Midori A. Yenari